InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Yeshwant Krishna, 董事. Officer active across 1 company, notably Verve Therapeutics, Inc.. In total, 6 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €16.5m. History available since 31 October 2022. The latest transaction was disclosed on 1 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Yeshwant Krishna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
6,108,442 股Common StockSEC:0000950170-25-099263:0
1,800,000 股@ US$10.00100.0% 占其流量Common StockSEC:0000950170-23-068199:0
标准退出：2024年2月29日 (T+90)
48,583 股0Common StockSEC:0000899243-22-035380:0
28,651 股0Common StockSEC:0000899243-22-035228:0
53,697 股0Common StockSEC:0000899243-22-034842:0
6,320,905 股Common StockSEC:0000899243-21-025307:0
6 条申报中的 6 条
About Yeshwant Krishna
Krishna Yeshwant is a Director at Verve Therapeutics, Inc. In this role, he participates in the strategy and governance of the company. His experience in the biotechnology field is valuable in guiding strategic decisions and supporting innovation at Verve Therapeutics, Inc.
